Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 21,456	$ 33,598
Marketable securities	5,726	18,944
Trade accounts receivable, net	5,813	5,427
Other current assets	4,085	6,172
Total current assets	37,080	64,141
Property and equipment, net	1,570	2,390
Intangibles, net	28,458	33,170
Goodwill	8,641	8,229
Lease right of use assets	4,017	4,720
Other assets	786	1,127
Total assets	80,552	113,777
Current liabilities:
Accounts payable and other accrued liabilities	6,672	5,989
Deferred revenue, current	5,853	4,145
Total current liabilities	12,525	10,134
Lease liabilities, long-term	5,994	5,977
Other long-term liabilities	106	76
Total liabilities	18,625	16,187
Commitments and contingencies (Note 17)
Shareholders’ equity:
Preferred stock (par value $0.001 per share, 2,500 authorized, 10 shares issued and outstanding at December 31, 2023 and December 31, 2022)	50	50
Common stock (par value $0.001 per share, 50,000 authorized, 20,379 and 20,260 shares issued and outstanding at December 31, 2023 and December 31, 2022, respectively)	20	20
Additional paid-in capital	376,189	367,692
Accumulated deficit	(311,768)	(265,809)
Accumulated other comprehensive loss	(2,564)	(4,363)
Total shareholders’ equity	61,927	97,590
Total liabilities and shareholders’ equity	$ 80,552	$ 113,777